Your browser doesn't support javascript.
loading
Rationalizing the Use of COVID-19 Questionable Efficacy Drugs in a Low Middle-income Country: A Hospital Tocilizumab Committee Experience.
Hegde, Naveen; Kumar, Ankit; Batra, Gurpreet K; Devnani, Mahesh; Rohilla, Rachna; Malhotra, Pankaj; Patil, Amol N.
  • Hegde N; Department of Pharmacology.
  • Kumar A; Department of Pharmacology.
  • Batra GK; Department of Pharmacology.
  • Devnani M; Associate Professor, Department of Hospital Administration, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh.
  • Rohilla R; Assistant Professor, Department of Pharmacology, AIIMS, Bhatinda.
  • Malhotra P; Professor, Department of Clinical Hematology and Medical Oncology.
  • Patil AN; Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Corresponding Author.
J Assoc Physicians India ; 71(3): 11-12, 2023 Mar.
Article en En | MEDLINE | ID: mdl-37354501
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article